Abstract
Myocardial infarction (MI) and subsequent progressive heart failure pathology is the major cause of death worldwide; however, the mechanism of this pathology remains unclear. The present work aimed at testing the hypothesis whether the inflammatory response is superimposed with the formation of bioactive lipid resolving molecules at the site of the injured myocardium in acute heart failure pathology post-MI. In this view, we used a robust permanent coronary ligation model to induce MI, leading to decreased contractility index with marked wall thinning and necrosis of the infarcted left ventricle. Then, we applied mass spectrometry imaging (MSI) in positive and negative ionization modes to characterize the spatial distribution of left ventricle lipids in the infarcted myocardium post-MI. After micro-extraction, liquid chromatography coupled to tandem mass spectrometry was used to confirm the structures of the imaged lipids. Statistical tools such as principal component analysis were used to establish a comprehensive visualization of lipid profile changes in MI and no-MI hearts. Resolving bioactive molecules such as resolvin (Rv) D1, RvD5, RvE3, 17-HDHA, LXA4, and 18-HEPE were detected in negative ion mode MSI, whereas phosphatidyl cholines (PC) and oxidized derivatives thereof were detected in positive ion mode. MSI-based analysis demonstrated a significant increase in resolvin bioactive lipids with comprehensive lipid remodeling at the site of infarction. These results clearly indicate that infarcted myocardium is the primary location of inflammation-resolution pathomechanics which is critical for resolution of inflammation and heart failure pathophysiology.
Similar content being viewed by others
Abbreviations
- AA:
-
Arachidonic acid
- AUC:
-
Area under curve
- DHA:
-
Docosahexaenoic acid
- EPA:
-
Eicosapentaenoic acid
- FA:
-
Fatty acids
- HDHA:
-
Hydroxydocosahexaenoic acid
- HEPE:
-
Hydroxyeicosapentaenoic acid
- HETEs:
-
Hydroperoxyeicosatetraenoic acid
- LC-MS/MS:
-
Liquid chromatography-mass spectrometry
- LMs:
-
Lipid mediators
- LTs:
-
Leukotrienes
- LV:
-
Left ventricle
- LX:
-
Lipoxins
- MALDI:
-
Matrix-assisted laser desorption ionization
- MI:
-
Myocardial infarction
- MRM:
-
Multiple reaction monitoring
- MSI:
-
Molecular mass spectrometry imaging
- PCA:
-
Principal component analysis
- PL:
-
Phospholipids
- Rv:
-
Resolvins
- TX:
-
Thromboxane
References
Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, et al. Heart failure: preventing disease and death worldwide. ESC Heart Failure. 2014;1(1):4–25.
Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368–78.
Ertl G, Frantz S. Healing after myocardial infarction. Cardiovasc Res. 2005;66(1):22–32.
Grey AC, Gelasco AK, Section J, Moreno-Rodriguez RA, Krug EL, Schey KL. Molecular morphology of the chick heart visualized by MALDI imaging mass spectrometry. Anat Rec (Hoboken, NJ : 2007). 2010;293(5):821–8.
Trim PJ, Henson CM, Avery JL, McEwen A, Snel MF, Claude E, et al. Matrix-assisted laser desorption/ionization-ion mobility separation-mass spectrometry imaging of vinblastine in whole body tissue sections. Anal Chem. 2008;80(22):8628–34.
Gessel MM, Norris JL, Caprioli RM. MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery. J Proteome. 2014;107:71–82.
Jones EE, Powers TW, Neely BA, Cazares LH, Troyer DA, Parker AS, et al. MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma. Proteomics. 2014;14(7–8):924–35.
De Sio G, Smith AJ, Galli M, Garancini M, Chinello C, Bono F, et al. A MALDI-mass spectrometry imaging method applicable to different formalin-fixed paraffin-embedded human tissues. Mol BioSyst. 2015;11(6):1507–14.
Diehl HC, Beine B, Elm J, Trede D, Ahrens M, Eisenacher M, et al. The challenge of on-tissue digestion for MALDI MSI—a comparison of different protocols to improve imaging experiments. Anal Bioanal Chem. 2015;407(8):2223–43.
Angel PM, Spraggins JM, Baldwin HS, Caprioli R. Enhanced sensitivity for high spatial resolution lipid analysis by negative ion mode matrix assisted laser desorption ionization imaging mass spectrometry. Anal Chem. 2012;84(3):1557–64.
Angel PM, Bayoumi AS, Hinton RB, Ru Su Y, Bichell D, Mayer JE, et al. MALDI imaging mass spectrometry as a lipidomic approach to heart valve research. J Heart Valve Dis. 2016;25(2):240–52.
Steurer S, Singer JM, Rink M, Chun F, Dahlem R, Simon R, et al. MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays. Urol Oncol. 2014;32(8):1225–33.
Kofeler HC, Fauland A, Rechberger GN, Trotzmuller M. Mass spectrometry based lipidomics: an overview of technological platforms. Meta. 2012;2(1):19–38.
Bure C, Ayciriex S, Testet E, Schmitter JM. A single run LC-MS/MS method for phospholipidomics. Anal Bioanal Chem. 2013;405(1):203–13.
Ma Y, Halade GV, Zhang J, Ramirez TA, Levin D, Voorhees A, et al. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Cir Res. 2013;112(4):675–88.
Lopez EF, Kabarowski JH, Ingle KA, Kain V, Barnes S, Crossman DK, et al. Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction. Am J Physiol Heart Circ Physiol. 2015;308(4):H269–80.
Halade GV, Kain V, Ingle KA (2017) Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology. Am J Physiol Heart Circ Physiol. :ajpheart 00528 02017.
Halade GV, Kain V, Black LM, Prabhu SD, Ingle KA. Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction. Aging. 2016;8(11):2611–34.
Halade GV, Ma Y, Ramirez TA, Zhang J, Dai Q, Hensler JG, et al. Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice. Am J Physiol Heart Circ Physiol. 2013;305(12):H1830–42.
Heaberlin JR, Ma Y, Zhang J, Ahuja SS, Lindsey ML, Halade GV. Obese and diabetic KKAy mice show increased mortality but improved cardiac function following myocardial infarction. Cardiovasc Pathol : the official journal of the Society for Cardiovascular Pathology. 2013;22(6):481–7.
Ejsing CS, Sampaio JL, Surendranath V, Duchoslav E, Ekroos K, Klemm RW, et al. Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry. Proc Natl Acad Sci U S A. 2009;106(7):2136–41.
Colas RA, Shinohara M, Dalli J, Chiang N, Serhan CN. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am J Physiol Cell Physiol. 2014;307(1):C39–54.
Thiele H, Heldmann S, Trede D, Strehlow J, Wirtz S, Dreher W, et al. 2D and 3D MALDI-imaging: conceptual strategies for visualization and data mining. Biochim Biophys Acta. 2014;1844(1 Pt A):117–37.
Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8(5):349–61.
Patterson NH, Doonan RJ, Daskalopoulou SS, Dufresne M, Lenglet S, Montecucco F, et al. Three-dimensional imaging MS of lipids in atherosclerotic plaques: open-source methods for reconstruction and analysis. Proteomics. 2016;16(11–12):1642–51.
Halade GV, Kain V, Ingle KA, Prabhu SD. Interaction of 12/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing. Am J Physiol Heart Circ Physiol. 2017;313(1):H89–H102.
Halade GV, Kain V. Obesity and cardiometabolic defects in heart failure pathology. Compr Physiol. 2017;7(4):1463–77.
Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101.
Halade GV, Rahman MM, Bhattacharya A, Barnes JL, Chandrasekar B, Fernandes G. Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice. J Immunol. 2010;184(9):5280–6.
Halade GV, Jin YF, Lindsey ML. Roles of saturated vs. polyunsaturated fat in heart failure survival: not all fats are created equal. Cardiovasc Res. 2012;93(1):4–5. https://doi.org/10.1093/cvr/cvr298.
Menger RF, Stutts WL, Anbukumar DS, Bowden JA, Ford DA, Yost RA. MALDI mass spectrometric imaging of cardiac tissue following myocardial infarction in a rat coronary artery ligation model. Anal Chem. 2012;84(2):1117–25.
Fruhwirth GO, Loidl A, Hermetter A. Oxidized phospholipids: from molecular properties to disease. Biochim Biophys Acta. 2007;1772(7):718–36.
Leitinger N. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res. 2005;49(11):1063–71.
Niki E, Yoshida Y, Saito Y, Noguchi N. Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun. 2005;338(1):668–76.
Spickett CM, Dever G. Studies of phospholipid oxidation by electrospray mass spectrometry: from analysis in cells to biological effects. BioFactors (Oxford, England). 2005;24(1–4):17–31.
Subbanagounder G, Deng Y, Borromeo C, Dooley AN, Berliner JA, Salomon RG. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells. Vasc Pharmacol. 2002;38(4):201–9.
Erridge C, Spickett CM. Oxidised phospholipid regulation of Toll-like receptor signalling. Redox Rep : Communications in Free Radical Research. 2007;12(1):76–80.
Bochkov VN, Leitinger N. Anti-inflammatory properties of lipid oxidation products. J Mol Med (Berlin, Germany). 2003;81(10):613–26.
Spiteller G. Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products. Free Radic Biol Med. 2006;41(3):362–87.
Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res. 2010;70(20):8117–26.
Deigner HP, Hermetter A. Oxidized phospholipids: emerging lipid mediators in pathophysiology. Curr Opin Lipidol. 2008;19(3):289–94.
Schneider C, Porter NA, Brash AR. Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J Biol Chem. 2008;283(23):15539–43.
Tourki B, Halade G. Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling. FASEB J : official publication of the Federation of American Societies for Experimental Biology. 2017;31(10):4226–39.
Kain V, Prabhu SD, Halade GV. Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res Cardiol. 2014;109(6):444.
Acknowledgements
We acknowledge the support from National Institutes of Health [AT006704 and HL132989] and The University of Alabama at Birmingham (UAB) Pittman scholar award to GVH, American Heart Association postdoctoral fellowship POST31000008 to VK, and Idex program from University of Bordeaux, France, to BF.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
ESM 1
(PDF 707 kb)
Rights and permissions
About this article
Cite this article
Halade, G.V., Dorbane, A., Ingle, K.A. et al. Comprehensive targeted and non-targeted lipidomics analyses in failing and non-failing heart. Anal Bioanal Chem 410, 1965–1976 (2018). https://doi.org/10.1007/s00216-018-0863-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-018-0863-7